A patient was being treated with a drug that interfaces with the activity of enzyme pyruvate ferredoxin oxidoreductase; Which of the following is the most likely organism causing infection in this patient?
Pyruvate ferredoxin oxidoreductase is a key enzyme in certain metabolic pathways. I remember that this enzyme is part of the acetyl-CoA pathway, which is used by some anaerobic organisms. Specifically, I think it's found in parasites like E. histolytica. Let me confirm that.
E. histolytica is an amoeba that causes amoebiasis. The drug metronidazole is commonly used against it. Metronidazole's mechanism involves being reduced by ferredoxin, which is part of the pyruvate ferredoxin oxidoreductase system in the parasite. This reduction activates the drug, making it toxic to the organism.
Now, looking at the options, the correct answer should be Entamoeba histolytica. The other options would be other pathogens that don't rely on this enzyme. For example, Giardia might use a different pathway. Bacteria like Bacteroides might have different enzymes. So, the key here is linking the enzyme to the specific organism and the drug's mechanism.
I should also mention why the other options are wrong. Giardia uses a different enzyme system, so the drug wouldn't target it. Bacteria like E. coli or Salmonella don't have this enzyme. Protozoa like Plasmodium have different metabolic pathways. The clinical pearl here is that metronidazole is effective against E. histolytica and Giardia, but the enzyme connection is specific to E. histolytica. That's a high-yield fact for exams.
**Core Concept**
Pyruvate ferredoxin oxidoreductase is a key enzyme in the metabolism of *Entamoeba histolytica*, a protozoan parasite. This enzyme is absent in human cells, making it a therapeutic target for antiprotozoal drugs like metronidazole, which requires reduction by ferredoxin to exert its cytotoxic effect.
**Why the Correct Answer is Right**
*Entamoeba histolytica* relies on pyruvate ferredoxin oxidoreductase to generate energy anaerobically. Metronidazole, a prodrug, is reduced by ferredoxin (a component of this enzyme system) to form reactive free radicals that damage the parasite’s DNA. This mechanism selectively targets *E. histolytica* without harming human cells, making it the most likely organism in this scenario.
**Why Each Wrong Option is Incorrect**
**Option A:** *Giardia lamblia* uses pyruvate:ferredoxin oxidoreductase but is typically treated with metronidazole as well. However, the question specifically implicates pyruvate **ferredoxin** oxidoreductase, which is unique to *E. histolytica*.
**Option B:** *Plasmodium falciparum* employs a different metabolic pathway involving cytochrome b and is targeted by antimalarials like chloroquine.
**Option C:** *Bacteroides fragilis* is a Gram-negative ana